A Phase II, Single-Center, Randomized, Parallel Group, Multiple Administration, Double-Blind, Placebo-Controlled Study to Evaluate the Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation.
Phase of Trial: Phase II
Latest Information Update: 03 Jan 2015
At a glance
- Drugs Relenopride (Primary)
- Indications Constipation
- Focus Pharmacodynamics
- Sponsors SK Life Science
- 02 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Dec 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jan 2013 Planned End Date changed from 1 Apr 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.